Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Quentin30on Feb 27, 2024 3:26pm
149 Views
Post# 35902202

Dilution...

Dilution...Riddle me this... what company is worth Billions, yet has diluted all time shareholders to the tune of 98.7% ?  Is that how the CEO creates shareholder value ?
 
What company announces that it's technology is ratified by the mere existence of its partnership with a hitherto unknown Chinese company, also with no approved medicines, which has subsequently removed all reference to Pela from its future pipeline?

What company has already failed a Phase III for its lead biologic ?

What company barely has enough money to keep the lights on each month ?

What Company has gone through three CMOs in 6 years ?

What Company has paid shills who frequent this BB and promise rainbows, unicorns and wealth beyond imagination?

What Company has been "on the cusp" for over ten years... has been claiming to be Phase III ready for 6 years and has missed every timeline it has ever proposed..?

And finally, what company's core patents start expiring in 2027..?

Yup, you're right Canaduh... they better sign a deal soon  or it'll all be over...  and the only mooning taking place will be from Matty pointing at azzak from a beach in Thailand.
<< Previous
Bullboard Posts
Next >>